Jefferies Group LLC Adaptive Biotechnologies Corp Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$10.12 - $28.9 $15,291 - $43,667
-1,511 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $14,699 - $21,520
-584 Reduced 27.88%
1,511 $18,000
Q3 2021

Sep 21, 2023
BUY
$30.02 - $39.87 $62,891 - $83,527
2,095 New
2,095 $71,000
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $62,891 - $83,527
2,095 New
2,095 $71,000
Q4 2019

Feb 13, 2020
SELL
$24.56 - $32.8 $309,357 - $413,148
-12,596 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$30.31 - $53.51 $381,784 - $674,011
12,596 New
12,596 $389,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email